Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Huanchen Sha

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9295-3906; OpenAlex author ID A5101462171. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Honokiol Suppresses Perineural Invasion of Pancreatic Cancer by Inhibiting SMAD2/3 Signaling. Last author DOI 10.3389/fonc.2021.728583↗
  2. Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways. Last author DOI 10.1155/2018/9482018↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyong Ma · 2 shared papers, 2018–2021 · strength 0.19
  2. Jie Li · 2 shared papers, 2018–2021 · strength 0.19
  3. Simei Zhang · 1 shared paper, 2021 · strength 0.11
  4. Zeen Zhu · 1 shared paper, 2021 · strength 0.11
  5. Wunai Zhang · 1 shared paper, 2021 · strength 0.11
  6. Liang Han · 1 shared paper, 2021 · strength 0.11
  7. Ying Xiao · 1 shared paper, 2021 · strength 0.11
  8. Tao Qin · 1 shared paper, 2021 · strength 0.11
  9. Zheng Wang · 1 shared paper, 2021 · strength 0.11
  10. Ke Chen · 1 shared paper, 2018 · strength 0.07
  11. Liankang Sun · 1 shared paper, 2018 · strength 0.07
  12. Liang Cheng · 1 shared paper, 2018 · strength 0.07
  13. Weikun Qian · 1 shared paper, 2018 · strength 0.07
  14. Junyu Cao · 1 shared paper, 2018 · strength 0.07
  15. Zhengdong Jiang · 1 shared paper, 2018 · strength 0.07
  16. Cancan Zhou · 1 shared paper, 2018 · strength 0.07
  17. Bin Yan · 1 shared paper, 2018 · strength 0.07
  18. Jiguang Ma · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.